Hepatitis B (krónikus): vizsgálatok itt: Kína
105 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
- Where
- Beijing
- Életkor
- 35 év to 65 év
- People
- 45
- Run by
- Fujian Akeylink Biotechnology Co., Ltd.
See details and how to joinNCT06263959 - No phaseTaking peopleResearch on Clinical Recovery and Maintenance Strategies for CHB
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 285
- Run by
- Beijing Municipal Administration of Hospitals
See details and how to joinNCT06803368 - No phaseTaking peopleMolecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 2000
- Run by
- Beijing Friendship Hospital
See details and how to joinNCT06779864 - No phaseCsak meghívásosClinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 180
- Run by
- Beijing Ditan Hospital
See details and how to joinNCT06777173 - Korai 1. fázisNot yet taking people in KínaAn Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis B
- Where
- Shanghai
- Életkor
- 18 év to 65 év
- People
- 20
- Run by
- Epigenic Therapeutics, Inc
See details and how to joinNCT06745973 - No phaseTaking peopleStudy on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.
- Where
- Chenzhou, Guangzhou, Hengyang
- Életkor
- 18 év to 65 év
- People
- 400
- Run by
- Xiangya Hospital of Central South University
See details and how to joinNCT06746701 - No phaseCsak meghívásosA Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
- Where
- Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Guanzhou, Harbin, Hefei, Shanghai, Shenyang, Shenzhen, Taiyuan, Tianjin, Ürümqi, Wuhan, Xiamen, Xi'an, Xi’an, Yanji, Zhengzhou
- Életkor
- 18 év and over
- People
- 350
- Run by
- Xiamen Amoytop Biotech Co., Ltd.
See details and how to joinNCT06707922 - No phaseTaking peopleTherapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b
- Where
- Guangzhou
- Életkor
- 18 év to 65 év
- People
- 100
- Run by
- Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT02883647 - No phaseTaking peopleThree Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF
- Where
- Guangzhou
- Életkor
- 12 év to 65 év
- People
- 150
- Run by
- Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT03920618 - No phaseTaking peopleLong-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure
- Where
- Guangzhou
- Életkor
- 18 év to 65 év
- People
- 300
- Run by
- Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT04310787 - No phaseTaking peopleCombination of DPMAS and Low Volume PE for Patients With HBV Related ACLF
- Where
- Guangzhou
- Életkor
- 18 év to 65 év
- People
- 200
- Run by
- Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT04597164 - No phaseTaking peopleExploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 120
- Run by
- Minghui Li
See details and how to joinNCT06696664 - 1. fázisNot yet taking people in KínaStudy of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients
- Where
- Hong Kong
- Életkor
- 18 év to 65 év
- People
- 36 worldwide
- Run by
- Epigenic Therapeutics, Inc
See details and how to joinNCT06661148 - No phaseTaking peopleImproved Sensitivity Detection of Serum HBsAg and HBsAg Reversion
- Where
- Shanghai
- Életkor
- 18 év to 65 év
- People
- 300
- Run by
- Huashan Hospital
See details and how to joinNCT06550622 - No phaseTaking peopleA Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B
- Where
- Beijing, Changchun, Chongqing, Nanjing, Wuhan
- Életkor
- 18 év to 50 év
- People
- 250
- Run by
- Tongji Hospital
See details and how to joinNCT06525909 - 4. fázisTaking peopleEfficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）
- Where
- Ningbo, Rui’an, Wenzhou, Yueqing
- Életkor
- 18 év to 60 év
- People
- 1500
- Run by
- First Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT06368882 - No phaseTaking peoplePegylated Interferon α in Previously Interferon-treated CHB（Leading Study）
- Where
- Shanghai
- Életkor
- 18 év to 65 év
- People
- 2016
- Run by
- Qing XIe
See details and how to joinNCT06323681 - No phaseTaking peopleNucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.
- Where
- Guangzhou
- Életkor
- 18 év to 65 év
- People
- 200
- Run by
- Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT04231565 - No phaseTaking peopleHBsAg Declined Patients Follow-up Study
- Where
- Guangzhou
- Életkor
- 18 év to 65 év
- People
- 100
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT05977283 - No phaseTaking peopleHepatitis B Vaccination After Neonatal Surgery
- Where
- Chongqing
- People
- 180
- Run by
- Children's Hospital of Chongqing Medical University
See details and how to joinNCT06023056 - No phaseTaking peopleFunctional Cure of Hepatitis B in HIV/HBV Co-infected Patients
- Where
- Guangzhou
- Életkor
- 18 év to 65 év
- People
- 60
- Run by
- Guangzhou 8th People's Hospital
See details and how to joinNCT05988879 - No phaseNot yet taking people in KínaPredictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy
- Where
- Fuzhou, Hefei, Jinan, Kunming, Nanjing, Shanghai, Taiyuan, Wuhan, Xi’an, Xuzhou
- Életkor
- 18 év to 80 év
- People
- 5000
- Run by
- Wen-hong Zhang
See details and how to joinNCT05965388 - No phaseTaking peopleReal-world Study Optimizing Nucleotide-analogues
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guiyang, Ha’erbin, Haikou, Hangzhou, Hefei, Jinan, Kunming, Lanzhou, Meizhou, Nanchang, Nanjing, Nanning, Qingdao, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Ürümqi, Wuhan, Xiamen, Xi’an, Xuzhou, Zhengzhou
- Életkor
- 18 év to 80 év
- People
- 20 000
- Run by
- Huashan Hospital
See details and how to joinNCT05937178 - Korai 1. fázisTaking peopleEfficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B
- Where
- Hefei
- Életkor
- 18 év to 60 év
- People
- 1084
- Run by
- Anhui Medical University
See details and how to joinNCT05922306 - No phaseTaking peopleDigitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 20 000
- Run by
- Ruijin Hospital
See details and how to joinNCT05870969